198 related articles for article (PubMed ID: 33243702)
1. Why Tumor Genetic Heterogeneity May Require Rethinking Cancer Genesis and Treatment.
Gottlieb B; Trifiro M; Batist G
Trends Cancer; 2021 May; 7(5):400-409. PubMed ID: 33243702
[TBL] [Abstract][Full Text] [Related]
2. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
3. Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance.
Singh A; Brito I; Lammerding J
Trends Cancer; 2018 Apr; 4(4):281-291. PubMed ID: 29606313
[TBL] [Abstract][Full Text] [Related]
4. Cancer drug resistance: A fleet to conquer.
Hussain S; Singh A; Nazir SU; Tulsyan S; Khan A; Kumar R; Bashir N; Tanwar P; Mehrotra R
J Cell Biochem; 2019 Sep; 120(9):14213-14225. PubMed ID: 31037763
[TBL] [Abstract][Full Text] [Related]
5. Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell.
Gao JP; Xu W; Liu WT; Yan M; Zhu ZG
World J Gastroenterol; 2018 Jun; 24(24):2567-2581. PubMed ID: 29962814
[TBL] [Abstract][Full Text] [Related]
6. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Biswas A; De S
Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
[TBL] [Abstract][Full Text] [Related]
7. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
Nijman SMB
Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
[TBL] [Abstract][Full Text] [Related]
8. The multi-factorial nature of clinical multidrug resistance in cancer.
Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Cause and Consequence of Tumor Heterogeneity.
Khatib S; Pomyen Y; Dang H; Wang XW
Trends Cancer; 2020 Apr; 6(4):267-271. PubMed ID: 32209440
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic changes of acid-adapted cancer cells push them toward aggressiveness in their evolution in the tumor microenvironment.
Damaghi M; Gillies R
Cell Cycle; 2017 Oct; 16(19):1739-1743. PubMed ID: 27635863
[TBL] [Abstract][Full Text] [Related]
11. Cell Competition Spurs Selection of Aggressive Cancer Cells.
Parker T; Madan E; Gupta K; Moreno E; Gogna R
Trends Cancer; 2020 Sep; 6(9):732-736. PubMed ID: 32327348
[TBL] [Abstract][Full Text] [Related]
12. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
13. Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint.
Rueff J; Rodrigues AS
Methods Mol Biol; 2016; 1395():1-18. PubMed ID: 26910065
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNAs in remodeling the tumor microenvironment (Review).
Pan Z; Tian Y; Niu G; Cao C
Int J Oncol; 2020 Feb; 56(2):407-416. PubMed ID: 31894326
[TBL] [Abstract][Full Text] [Related]
15. Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC).
Smith CIE
Semin Cancer Biol; 2017 Aug; 45():36-49. PubMed ID: 27865897
[TBL] [Abstract][Full Text] [Related]
16. Cancer Plasticity: The Role of mRNA Translation.
Lee LJ; Papadopoli D; Jewer M; Del Rincon S; Topisirovic I; Lawrence MG; Postovit LM
Trends Cancer; 2021 Feb; 7(2):134-145. PubMed ID: 33067172
[TBL] [Abstract][Full Text] [Related]
17. Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy.
Fais S; Venturi G; Gatenby B
Cancer Metastasis Rev; 2014 Dec; 33(4):1095-108. PubMed ID: 25376898
[TBL] [Abstract][Full Text] [Related]
18. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
19. Targeting of cancer stem cells by differentiation therapy.
Arima Y; Nobusue H; Saya H
Cancer Sci; 2020 Aug; 111(8):2689-2695. PubMed ID: 32462706
[TBL] [Abstract][Full Text] [Related]
20. Rare Mutations in Cancer Drug Resistance and Implications for Therapy.
Beckman RA; Loeb LA
Clin Pharmacol Ther; 2020 Sep; 108(3):437-439. PubMed ID: 32648584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
